文献速递肝胆胰外科

经胃内镜保胆手术治疗良性胆囊疾病的可行性

Feasibility of transgastric endoscopic gallbladder-preserving surgery for benign gallbladder diseases (with video).
PubMed 文献 · Surg Endosc · 2022-01-24

本研究于2020年6月至2021年1月纳入22例胆囊结石和/或胆囊息肉患者,行经胃内镜保胆手术(EGPS),评估其可行性。22例均成功完成手术,住院期间4例(18.2%)发生局限性腹膜炎,经保守治疗好转;中位随访4个月,1例残留结石,未见结石复发或相关死亡。结论认为经胃EGPS在选定良性胆囊疾病患者中似乎可行,但作为新技术仍需进一步研究其长期有效性。

要点

  • 22例良性胆囊疾病患者均成功完成经胃EGPS,中位手术时间118分钟。
  • 住院期间4例(18.2%)出现局限性腹膜炎,均经保守治疗恢复。
  • 中位随访4个月,1例残留结石,未见结石复发或相关死亡。

核心结论

  • 经胃EGPS在选定的良性胆囊疾病患者中似乎是可行的治疗方法。
  • 作为新技术,仍需进一步研究以探讨经胃EGPS的长期有效性。

研究设计与样本

  • 单臂研究,2020年6月至2021年1月共22例胆囊结石和/或胆囊息肉患者接受经胃EGPS。
  • 纳入患者包括8例多发结石、4例胆囊息肉合并结石、6例多发息肉、2例单发结石、2例单发息肉。
  • 主要观察指标为并发症发生率、残留胆囊结石及胆囊结石复发率。

主要发现

  • 经胃EGPS在22例(13女、9男)良性胆囊疾病患者中均成功完成。
  • 中位手术时间118分钟。
  • 住院期间4例(4/22,18.2%)发生局限性腹膜炎,经保守内科治疗成功恢复。
  • 无大出血、迟发出血、弥漫性腹膜炎或其他严重并发症。
  • 中位随访4个月,1例残留结石,无结石复发及与经胃EGPS相关的死亡。

临床怎么用

  • 对选定的良性胆囊疾病患者,经胃EGPS可作为保胆治疗的可行选择之一。
  • 术后需关注局限性腹膜炎等并发症,本研究中此类患者经保守治疗恢复。
  • 术后随访需评估残留结石与结石复发情况。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: With the increasing realization of the importance of gallbladder function, choledochoscopic gallbladder-preserving surgery has been advocated for benign gallbladder diseases. However, limited information is available regarding the use of endoscopic gallbladder-preserving surgery (EGPS) for patients with benign gallbladder diseases. The aim of this study was to evaluate the feasibility of EGPS for benign gallbladder diseases. METHODS: Between June 2020 and January 2021, 22 patients with gallbladder stones and/or gallbladder polyps were treated with EGPS. The main outcome measures included the rate of complications, residual gallbladder stones, and gallbladder stone recurrence. RESULTS: In this study, transgastric EGPS was successfully performed in 22 patients (13 female, 9 male) with benign gallbladder diseases, and included 8 cases of multiple gallstones, 4 cases of gallbladder polyps with gallstones, 6 cases of multiple gallbladder polyps, 2 cases of single gallstone, and 2 case of singe gallbladder polyp. The median time of transgastric EGPS was 118 min. During hospitalization, 4 patients suffered localized peritonitis (4/22, 18.2%), and these patients successfully recovered after conservative medical treatment. None of the patients experienced massive bleeding, delayed bleeding, diffuse peritonitis, or any other serious complications. During the median follow-up of 4 months, 1 patient suffered residual gallstone, while no gallstone recurrence or deaths related to transgastric EGPS occurred in any patients. CONCLUSIONS: Transgastric EGPS appears to be a feasible treatment method in selected patients with benign gallbladder diseases. However, as it is a new technique, further studies are needed to explore the long-term effectiveness of transgastric EGPS.

来源:Surg Endosc,查看原文。版权归原作者所有。

引用

  1. Zhang Y, Mao XL, Zhou XB, et al. Feasibility of transgastric endoscopic gallbladder-preserving surgery for benign gallbladder diseases (with video). Surg Endosc. 2022. PMID: 35075524. doi:10.1007/s00464-021-08890-4

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。